3860 results for «289»
3860 results
Clinical benefits of co-registration IVUS, FFR and iFR pullback in daily PCI
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to learn how to use IVUS to guide vessel preparation and size stents and assess angioplasty results, how SyncVision IVUS co-registration can improve efficiency of angioplasty, and how iFR co-registration can guide angioplasty in patients with diffuse disease.
PCI optimisation: OCT and physiology in a complex multivessel disease case
18 Dec 2019 – From GulfPCR-GIM 2019
The patient is a 57-year-old male with high-risk factors and previous history of revascularisation. He presents with ischemic chest pain with NSTE-ACS. The baseline angiography shows multivessel disease and calcified LAD/D1 bifurcation (1,1,0).
The key objectives of this case are:
- Utility of FFR in physiological assessment of a...
Updates in TAVI therapies
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to learn more about the latest updates in TAVI therapies, and discover the unique features of Acurate neo and Lotus Edge, the clinical evidence of both Boston Scientific TAVI platforms, while learning all about the needs of cerebral protection during TAVI procedures.
All you need to know to start optimising outcomes in PCI: OCT and physiology
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this session on the new developments and future directions in functional coronary assessment to discover how and why physiology assessment/OCT could optimise procedural outcomes in PCI, and learn all about their main indications, the relevant indicators to be assessed, as well as the last changes...
Shaping the future of transcatheter valve interventions
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this sesson to discover the future perspectives and innovations on transcatheter valve interventions, and learn of a new therapy in high surgical risk patients with the Tendyne clinical programme, which eliminates mitral regurgitation.
Improving patient access and clinical outcomes for valvular heart disease
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session on valvular heart disease to learn more about the indication expansion for aortic stenosis patients and the implication of valve design choice for the patient's future, and discover some new treatment options for mitral valve disease.
Interactive Case Corner 1 - Thrombosed AVG, bifurcation lesions & diffuse CAD
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to discover a selection of challenging clinical cases, such as myocardial revascularisation in diffuse CAD, PCI of bifurcation lesion with DK crush technique, angioplasty of totally thrombosed arteriovenous graft, and more!
Interactive Case Corner 2 - Rasmussen's aneurysm, recurrent haemoptysis & acute limb ischemia
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to discover a selection of challenging and complex clinical cases, such as rotational atherectomy with distal left radial approach, endovascular management of Rasmussen's aneurysm, recurrent haemoptysis caused by a large pulmonary artery aneurysm, and more!
Interactive Case Corner 4 - Wandering stent
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to discover the case of a high-risk patient accepted for LM and multivessel PCI, and learn more about the transulnar approach strategy and benefits.
Interactive Case Corner 5 - Coronary CTO & ACS NSTEMI
18 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to discover two clinical cases on coronary CTO and ACS NSTEMI, and learn how to reduce radiation exposure to the patient during the procedure.
Interactive Case Corner 6 - SCAD, LMS lesions & stent thrombosis
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to learn from complex clinical cases, how to manage challenging scenarios and complications, such as SCAD in three different vessels, acute stent thrombosis, LMS lesions, and more!
Interactive Case Corner 7 - SVG thrombosis, twisted coronary catheter & stent loss
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to learn from challenging clinical cases how to manage various complications, such as SVG thrombosis in STEMI, twisted coronary catheter, total stent loss and more!
Interactive Case Corner 8 - LICA stenosis & complex LM PCI
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to discover two challenging cases: a very distal stenosis in LICA with aberrant origin, where you will learn more about arch anomalies, and a complex LM PCI, where you will gain insight into the role of rotablation and OCT.
Interactive Case Corner 9 - Complex TAVI & PCI
19 Dec 2019 – From GulfPCR-GIM 2019
Consult this session to discover a selection of complex PCI and TAVI cases, such as TAVR in low-lying coronary ostium and narrow sinus of valsalva, complex left main primary PCI for a patient with cardiogenic shock, renal disease with bilateral critical renal artery stenosis, and more!
The future of hypertension management: another treatment option
13 Dec 2020 – From AICT-AsiaPCR 2020
Join A. Fong and Y-H. Lee as they share their experience on the management of hypertension and the latest information on renal denervation.
Latest evidence on cardiogenic shock management
13 Dec 2020 – From AICT-AsiaPCR 2020
Find out more about the latest evidence on the management of cardiogenic shock followed by key messages to improve the outcome of very sick cardiogenic shock patients.
Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation
25 Jun 2020 – From PCR e-Course 2020
A common exclusion for transcatheter mitral valve implantation (TMVI) is a small predicted neo-left ventricular outflow tract (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...
New TMVI therapy to eliminate mitral regurgitation. Evidence and patient selection
26 Jun 2020 – From PCR e-Course 2020
Watch this video if you want to get the latest update on the first commercially available TMVI therapy (Tendyne), to learn about Tendyne clinical experience and how to identify the best candidates for this novel therapy.
Two-year outcomes of Tendyne Transcatheter Mitral Valve Implementation (TMVI) to treat symptomatic severe mitral regurgitation
Learn more about the 2-year outcomes of the first 100 patients treated as part of the Tendyne Expanded Clinical Study, and how the latest Tendyne clinical evidence may change the way the heart team treats mitral regurgitation.
Videos included on this page: the Hot Line presentation and...
Shaping care pathways for severe aortic stenosis patients in a COVID-19 context
Watch this roundtable discussion on the management of aortic stenosis in the context of the COVID-19 pandemic and how to readdress the treatment options and pathways to serve the needs of the patients in this difficult global crisis.
